findmyKOL
Clinical trialNCT06388967RecruitingObservational

Pancreatic Cancer Detection Consortium

SponsorCity of Hope Medical CenterEnrollment2,000Pancreatic AdenocarcinomaPancreatic CancerPancreatic Cancer Non-resectablePancreatic Cancer ResectablePancreatic Cancer StagePancreatic Cancer Stage 0+7 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Japan
  • Nagoya University

    Nagoya, Japan

    Masamichi HayashiYasuhiro Kodera
    Recruiting
South Korea
  • Asan Medical Center

    Seoul, South Korea

    Song Cheol Kim
    Recruiting
United States
  • Translational Genomics Research Institute

    Phoenix, Arizona, United States

    Daniel Von HoffDerek CridebringHaiyong Han
    Recruiting
  • Honorhealth

    Scottsdale, Arizona, United States

    Erkut Borazanci
    Recruiting
  • City of Hope Medical Center

    Monrovia, California, United States

    Ajay GoelAlessandro MannucciCaiming XuStanley HamiltonVincent Chung
    Recruiting
  • Hoag Center

    Newport Beach, California, United States

    Michael Demeure
    Recruiting
  • Osf Healthcare

    Peoria, Illinois, United States

    Chandler Wilfong
    Recruiting
  • Ochsner Medical Center

    Jefferson, Louisiana, United States

    John Bolton
    Recruiting
  • Atlantic Health System

    Morristown, New Jersey, United States

    Angela AlistarEric Whitman
    Recruiting
  • Piedmont Medical Center

    Rock Hill, South Carolina, United States

    Andrew PageEyal Meiri
    Recruiting
  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    Douglas Evans
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Mar 2023
Primary completion
30 Dec 2030
Completion
30 Dec 2030
Last update posted
16 Jul 2026
Registered enrollment
2,000
Registry id
NCT06388967

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.